Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
Journal Title: Translational Research in Urology - Year 2020, Vol 2, Issue 3
Abstract
Introduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are proposed for use in surgical wound sites as an absorbable hemostat and in this study, we checked its efficacy. Methods This study was run under the Tehran University of Medical Science Ethics Committee observation based on the clinical trial registry criteria (IRCT20190624043991N1). Total numbers of 42 percutaneous nephrolithotomies (PCNL) patients were enrolled, 21 cases hemostatic powder and 21 controls. Hemostatic powder pumped into Amplatz sheath before its extraction. Results The mean age of the case and control groups was 42.1±19.5, and 42.1±18.5 years, respectively. The median stone size was 11.3±1.85cm. Overall, the differences between sex, age, stone size, and location were not statistically significant in the two groups (p-value˃0.05). Serum hemoglobin reduction following PCNL was significant in both groups compared to the serum level before surgery (p-value<0.001). However, the difference was not significant between case and control groups postoperatively (p-value=0.727). Yet, postoperative serum creatinine reduction was not significantly different between the two groups compared to preoperative serum levels (p-value>0.05). Conclusions The present study showed that microporous polysaccharide hemosphere (MPH) did not affect bleeding reduction, hemoglobin decline, and postoperative blood transfusion, and hospital stay.
Authors and Affiliations
Seyed Mohammad Kazem Aghamir; Mahdi Ramezani-binabaj; Fatemeh Khatami; Behrooz Fatahi
Keywords
Related Articles
- EP ID EP704202
- DOI 10.22034/TRU.2020.257231.1047
- Views 80
- Downloads 0
Measuring Stone Free Rate after Mini Percutaneous Nephrolithotomy: Radiography, Ultrasound, or CT scan?
Stone-free rate (SFR) after treatment can be estimated by plain radiography and ultrasonography, or computed tomography (CT) scanning. Based on the guidelines, CT is the primary method for SFR estimation after PCNL (perc...
Liquid Biopsy in Prostate Cancer Diagnosis and Prognosis: A Narrative Review
Prostate cancer involves a considerable percentage of men worldwide and as be postulated; prostate cancer epidemiology is not restricted to a specific country. Despite tremendous efforts that have been made regarding pro...
The Relationship between Graft Function and Liver Function after Kidney Transplantation: A Retrospective Cohort Study
Introduction After kidney transplantation, several factors should be checked to predict the risk of rejection. Liver enzymes are such predicting factors so liver function test abnormalities (LFTA) can consider the rejec...
Comparison of the Tamsulosin and Tolterodine Effectiveness in Stent-Related Symptoms Reduction
Introduction To compare the effectiveness of tamsulosin and Tolterodine in reducing stent-related symptoms with each other and with the control group we performed this randomized clinical trial. Methods 150 patients a...
The Characteristics and Outcomes of Patients Treated with Percutaneous Nephrolithotomy According to the Preoperative Renal Function Levels
Introduction The principles of nephrolithiasis therapy in patients with chronic kidney disease are the same as in patients with normal kidneys. Percutaneous nephrolithotomy (PNL) is the standard treatment for patients w...